Question 1

What is Shenzhen Innovation Immunotechnology?

Accepted Answer

Shenzhen Innovation Immunotechnology is a Entity.

Question 2

How often does Shenzhen Innovation Immunotechnology appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was Shenzhen Innovation Immunotechnology first tracked by Ergen?

Accepted Answer

First tracked on Jul 28, 2026.

Question 4

When was Shenzhen Innovation Immunotechnology last mentioned in news?

Accepted Answer

Last active on Jul 30, 2026.

Question 5

What is Shenzhen Innovation Immunotechnology's current news sentiment?

Accepted Answer

Aggregate sentiment score: 20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Shenzhen Innovation Immunotechnology in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Shenzhen Innovation Immunotechnology?

Accepted Answer

EUDA Health iPSC Cell Therapy Collaboration (Jul 28, 2026, 8 articles).

Question 8

How did the "EUDA Health iPSC Cell Therapy Collaboration" event impact Shenzhen Innovation Immunotechnology?

Accepted Answer

SIIT contributes NK and NK-TCR cell engineering capabilities and GMP manufacturing expertise, essential for developing the cell therapies.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.